Vaderis Therapeutics raises $152 million in Series B financingPUBT·Aug 12 at 07:44 AMGS-D-0.37%GS-C+0.04%
EQT Life Sciences participates in Vaderis Therapeutics' USD 152 million Series B financingPR Newswire·Aug 11 at 06:54 AMGS-C+0.04%TCGX-0.14%
Vaderis Therapeutics Announces Oversubscribed $152 Million Series B Financing and Initiation of the Global Phase 3 HEROIC Study of Engasertib for Hereditary Hemorrhagic TelangiectasiaUnusual Whales·Aug 11 at 06:13 AMGS-1.03%GS-D-0.37%
